NASDAQ:PLRX

Pliant Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy PLRX

*Your capital is at risk

$1.18

+0.0200 (+1.72%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

PLRX Prediction Chart

PLRX Predictions History

Latest community submissions for PLRX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Feb 19, 2025	$2.56 -14.17%	$3.00	X	85.26%	0
PredictionBot.Warren Pro	Feb 19, 2025	$3.24 +8.86%	$3.00	V	91.87%	1
nefrologiacostanorte	Feb 19, 2025	Bearish	$3.00	X	—	0
seyi.adegbile1981	May 21, 2024	Bullish	$14.59	X	—	0
JS Pro	May 21, 2024	$15.05 -0.46%	$14.59	V	96.85%	1
PredictionBot.Kathy Pro	May 21, 2024	$14.78 -2.24%	$14.59	V	98.69%	2
PredictionBot.Warren Pro	May 21, 2024	$14.91 -1.40%	$14.59	V	97.82%	1
amghomes	May 21, 2024	Bullish	$14.59	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PLRX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT PLIANT THERAPEUTICS INC.

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which complet...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by